Company intelligence / Profile preview
Aravive, Inc.
Houston, Texas, United Statesorpha.net ↗
- Ownership
- Public · ARAV
- Development stage
- Phase 3
01
Overview
Aravive was a clinical-stage biopharmaceutical company focused on developing transformative treatments for life-threatening diseases such as cancer and fibrosis. Its lead candidate, batiraxcept (AVB-S6/S6–500), an ultrahigh-affinity decoy protein targeting the GAS6/AXL pathway, reached Phase III trials in platinum-resistant recurrent ovarian cancer but failed to show efficacy over standard of care. Other programs included early-phase studies in clear cell renal cell carcinoma and pancreatic adenocarcinoma. The company has faced significant setbacks following the failure of its pivotal trial and has limited cash runway[7][9].
- Therapeutic areas
- OncologyCardiovascular
- Modalities
- Recombinant fusion proteins (decoy proteins)Monoclonal antibodies (in partnership/licensing context)Antibody fusion proteins
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
WuXi Biologics – collaboration to develop bispecific antibodies targeting oncology/fibrosis[1]3D Medicines – license agreement for batiraxcept development/commercialization in China region[1]
04
Financials
- Market cap
- $2.9M
- Total revenue
- $2.8M
- Enterprise value
- $-3.2M
Beyond the preview
Go deeper on Aravive, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Aravive, Inc..